Regional News

Global Times: What does pursuit of Chinese modernization look like in remote, less-developed areas like Liangshan?

BEIJING, Feb. 21, 2023 /PRNewswire/ -- When President Xi Jinping visited Liangshan Yi Autonomous Prefecture,Southwest China's Sichuan Province in February 2018, the region, home to the largest ethnic Yi community, was still engaged in a tough battle against extreme poverty. Due to its harsh natur...

2023-02-21 15:23 1395

Daqo New Energy to Announce Unaudited Results for the Fourth Quarter and Fiscal Year 2022 on February 28, 2023

SHANGHAI, Feb. 21, 2023 /PRNewswire/ -- Daqo New Energy Corp. (NYSE: DQ) ("Daqo New Energy" or the "Company"), a leading manufacturer of high-purity polysilicon for the global solar PV industry, today announced it plans to release its unaudited financial results for the fourth quarter and fiscal ...

2023-02-21 14:09 2537

SOHU.COM REPORTS FOURTH QUARTER AND FISCAL YEAR 2022 UNAUDITED FINANCIAL RESULTS

BEIJING, Feb. 21, 2023 /PRNewswire/ -- Sohu.com Limited (NASDAQ: SOHU) ("Sohu" or the "Company"),China's leading online media, video, and game business group, today reported unaudited financial results for the fourth quarter and fiscal year endedDecember 31, 2022. Fourth Quarter Highlights ...

2023-02-21 13:51 2879

YouLianCloud Officially Accesses Baidu ERNIE Bot, Driving the Development of Financial AIGC

SHANGHAI, Feb. 20, 2023 /PRNewswire/ -- On February 14, 2023, YouLianCloud announced to be the first batch of early experience officers of ERNIE Bot. Subsequently, YouLianCloud will fully experience ERNIE Bot 's ability to use AI to drive intelligent financial content production and jointly promo...

2023-02-21 11:15 1523

RVAC Medicines Secures HSA Approval to Initiate Phase 1B Clinical Trial in Singapore

SINGAPORE, Feb. 20, 2023 /PRNewswire/ -- RVAC Medicines Pte. Ltd. (RVAC), a messenger RNA (mRNA) technology platform company, announced today that it has secured the approval from the Health Sciences Authority (HSA) to initiate Phase 1B clinical trial in Singapore to evaluate the safety and immuno...

2023-02-21 10:00 1750

Bridge Biotherapeutics Presents Phase 2a Clinical Trial Results For BBT-401, a Drug Candidate to Treat Ulcerative Colitis

* BBT-401 meets safety endpoints achieved in previous clinical studies * The drug candidate did not achieve an improved clinical response compared to the placebo study group * 54.5% of the treatment cohort exhibited a valid treatment response to orally administered BBT-401 SEONGNAM, South Ko...

2023-02-21 07:00 1579

Emotn launches the N1 - A Netflix Officially-Licensed Home Projector for enhancing the viewing experience of movies and shows

Featuring access to the Netflix library at the press of a button, the N1 delivers a theater-like audio-visual experience with Dolby Audio through dual 5W speakers and a large projection size of up to 120 inches TUMWATER, Wash., Feb. 20, 2023 /PRNewswire/ -- Dynamic smart projector brand, Emotn,a...

2023-02-21 01:00 1834

Which category takes best performance on TikTok? Key Findings From Shoplus 2022 TikTok Trends Report

HONG KONG, Feb. 20, 2023 /PRNewswire/ -- Report: "Her Economy" is on the rise, Beauty and Personal Care, Womenswear and Lingerie accounted for 44% in TikTok e-commerce As the most welcomed TikTok analytics tool , Shoplus released its TikTok E-commerce Product Trends Rep...

2023-02-21 01:00 2051

EM Coretech to Mass-Produce World's First EMIC Next Year

SEOUL, South Korea, Feb. 20, 2023 /PRNewswire/ -- EM Coretech, working with a Korean 8-in semiconductor foundry, is mass-producing the world's first electromagnetic interference management IC (EMIC). An EMIC removes electromagnetic waves generated by electronic parts and prevents device malfunct...

2023-02-21 01:00 1670

EDAN Pictured the Long-Term Regional Development Plans with the Minister Counselor of the Chinese Embassy in Kenya

NAIROBI, Kenya, Feb. 20, 2023 /PRNewswire/ -- Minister Counselor of the Chinese Embassy inKenya, Yijun Zhang held a meeting on February 7, 2023 with Alex You, Global Marketing & Strategic Operations Director, andVincent Bi, Customer Service & Healthcare Informatics Director ofEdan Instruments, In...

2023-02-21 00:15 1784

MINDLAX REVOLUTIONIZES SLEEP SOLUTIONS WITH VIBROACOUSTIC SLEEPING MAT

The MindLax Sleeping Mat uses tactile-aural mechanisms that trigger the body's natural processes to induce relaxation and aid better sleep COLORADO SPRINGS, Colo., Feb. 20, 2023 /PRNewswire/ -- MindLax, the leading innovator in natural sleep and relaxation products and maker of the MindLax Sleep...

2023-02-21 00:00 1792

naked Group and Trip.com Group Announce Joint Venture to Expand Cooperation in the Sustainable Luxury Lifestyle Sector

SHANGHAI, Feb. 20, 2023 /PRNewswire/ -- naked Group Ltd. and Trip.com Group (NASDAQ: TCOM) have announced a new joint venture focused on expanding cooperation in the sustainable luxury sector inChina and globally. The announcement was made at a signing ceremony held at the naked Stables in Mogan...

2023-02-20 22:15 2027

Celltrion and LISCure Biosciences announce strategic collaboration to develop novel microbiome treatment for Parkinson's disease

* Co-research and co-development of novel microbiome therapeutics * Discovery of new candidates to meet high unmet medical needs in Parkinson's disease SEOUL, South Korea, Feb. 20, 2023 /PRNewswire/ -- LISCure Biosciences Inc., a clinical-stage biotech developing advanced microbiome technology...

2023-02-20 22:00 1853

Thai govt and private sector leaders announce collaboration to support Thailand's bid to host Expo 2028 Phuket Thailand

BANGKOK, Feb. 20, 2023 /PRNewswire/ -- Thailand's Deputy Prime Minister and Minister of Public Health, Mr. Anutin Charnvirakul, and leaders of the Thai private sector have a formal meeting to discuss collaboration in supporting Thailand's bid to host Expo 2028 Phuket Thailand. With the bidding pro...

2023-02-20 21:01 1950

ARTiSTORY facilitates 'Season of Impressionists' afternoon tea experience for Fairmont Singapore in partnership with the National Gallery, London.

SINGAPORE, Feb. 20, 2023 /PRNewswire/ -- ARTiSTORY, the National Gallery, London and Anti:dote, Fairmont Singapore presentSeason of Impressionists, a sunflower-themed afternoon tea inspired by the works of Post-Impressionist Dutch painter, Vincent van Gogh - the first in a four-part series of art...

2023-02-20 21:00 1891

NOVOSENSE improves industrial system design with one-chip isolated power supply

SHANGHAI, Feb. 20, 2023 /PRNewswire/ -- In view of high voltage, safety, noise immunity and other factors in industrial system design, the demand for isolated design is more and more extensive, and transferring signal/power across isolation barrier has been one of the common challenges for design...

2023-02-20 19:43 1457

Maypharm CO, LTD., launched a new CE filler: Multi-layered Phasic Hyaluronic Acid with lidocaine and CE approved MayFill Filler

SEOUL, South Korea and NEW YORK, Feb. 20, 2023 /PRNewswire/ -- Maypharm, a brand holder of such popular products as Metoo fill, Sedy fill, Metox, Mennus, Hairna, Eyebella, has been busy with developing new products in Aestheticians market. Metoo Fill is the first CE approved filler made by Maypha...

2023-02-20 19:03 1656

Tencent Music Entertainment Group to Report Fourth Quarter and Full Year 2022 Financial Results on March 21, 2023 Eastern Time

SHENZHEN, China, Feb. 20, 2023 /PRNewswire/ -- Tencent Music Entertainment Group ("TME", or the "Company") (NYSE: TME and HKEX: 1698), the leading online music and audio entertainment platform in China, today announced that it will report its unaudited financial results for the fourth quarter and...

2023-02-20 18:00 2631

iQIYI Launches First All-Immersive Entertainment Experience The Luoyang VR Project in Shanghai

BEIJING, Feb. 20, 2023 /PRNewswire/ -- iQIYI, an innovative market-leading online entertainment service inChina, officially unveiled its Luoyang Virtual Reality (VR) Project inShanghai on Feb. 18, showcasing the industry's first-ever all-immersive entertainment experience which incorporates VR t...

2023-02-20 13:01 1928

Daewoong Pharmaceutical Reaches Sales of KRW 1.16 Trillion in 2022, Fexuclue Leads The Highest Revenue

- Hitting a record high sale with business profits of KRW 106 billion and net profits ofKRW 80.1 billion according to the accounting of 2022 - Not only stable positioning of Fexuclue but also achievement obtaining a permit of new medicine for Envlo SEOUL, South Korea, Feb. 19, 2023 /PRNewswire/ ...

2023-02-20 12:29 1680